IDEAS home Printed from https://ideas.repec.org/a/wly/reggov/v15y2021i3p969-986.html
   My bibliography  Save this article

The ratio of vision to data: Promoting emergent science and technologies through promissory regulation, the case of the FDA and personalised medicine

Author

Listed:
  • Stuart Hogarth
  • Paul Martin

Abstract

Pharmacogenetic tests provide genetic data to tailor drug treatment and were widely predicted to be one of the first fruits of the Human Genome Project. In the mid‐2000s, the US Food and Drugs Administration (FDA) became an advocate for pharmacogenetic testing, but its efforts to build a market for this new technology brought the agency into dispute with other regulatory actors over the type of evidence needed for the adoption of pharmacogenetic testing, in particular the importance of randomized control trials. The warfarin case highlights the tension between a new form of promissory regulation driven by future expectations and FDA's established role as protector of public health; and the controversy can be conceptualized as a struggle over regulatory epistemologies within a complex polycentric regulatory space. Our case study addresses two themes central to the burgeoning scholarship on the governance of emergent science and technologies (EST): the political economy of regulation, in particular the role that regulators play in creating markets for EST; and the epistemological politics of regulatory science, in particular the controversy that arises when regulators modify scientific standards to accommodate EST. Linking these two themes is the concept of promissory regulation: the idea that regulatory policy may be shaped by an institutional commitment to the transformational potential of EST. This concept sheds new light on the neo‐mercantilist nature of contemporary regulatory capitalism.

Suggested Citation

  • Stuart Hogarth & Paul Martin, 2021. "The ratio of vision to data: Promoting emergent science and technologies through promissory regulation, the case of the FDA and personalised medicine," Regulation & Governance, John Wiley & Sons, vol. 15(3), pages 969-986, July.
    • Handle: RePEc:wly:reggov:v:15:y:2021:i:3:p:969-986
    DOI: 10.1111/rego.12360
    as

    Download full text from publisher

    File URL: https://doi.org/10.1111/rego.12360
    Download Restriction: no
    File URL: https://libkey.io/10.1111/rego.12360?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Hopkins, Michael M. & Martin, Paul A. & Nightingale, Paul & Kraft, Alison & Mahdi, Surya, 2007. "The myth of the biotech revolution: An assessment of technological, clinical and organisational change," Research Policy, Elsevier, vol. 36(4), pages 566-589, May.
    2. Ozieranski, Piotr & McKee, Martin & King, Lawrence, 2012. "The politics of health technology assessment in Poland," Health Policy, Elsevier, vol. 108(2), pages 178-193.
    3. Hogarth, Stuart, 2015. "Neoliberal technocracy: Explaining how and why the US Food and Drug Administration has championed pharmacogenomics," Social Science & Medicine, Elsevier, vol. 131(C), pages 255-262.
    4. Majone, Giandomenico, 1997. "From the Positive to the Regulatory State: Causes and Consequences of Changes in the Mode of Governance," Journal of Public Policy, Cambridge University Press, vol. 17(2), pages 139-167, May.
    5. Kuhlmann, Stefan & Stegmaier, Peter & Konrad, Kornelia, 2019. "The tentative governance of emerging science and technology—A conceptual introduction," Research Policy, Elsevier, vol. 48(5), pages 1091-1097.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Andrew B. Whitford & Derrick Anderson, 2021. "Governance landscapes for emerging technologies: The case of cryptocurrencies," Regulation & Governance, John Wiley & Sons, vol. 15(4), pages 1053-1070, October.
    2. Ian Loader & Adam White, 2017. "How can we better align private security with the public interest? Towards a civilizing model of regulation," Regulation & Governance, John Wiley & Sons, vol. 11(2), pages 166-184, June.
    3. Seokbeom Kwon & Jan Youtie & Alan Porter & Nils Newman, 2024. "How does regulatory uncertainty shape the innovation process? Evidence from the case of nanomedicine," The Journal of Technology Transfer, Springer, vol. 49(1), pages 262-302, February.
    4. Xhemazie Ibraimi, 2020. "Legal Status Of Agencies In Kosovo," Perspectives of Law and Public Administration, Societatea de Stiinte Juridice si Administrative (Society of Juridical and Administrative Sciences), vol. 9(2), pages 318-325, December.
    5. Bartle, Ian & Vass, Peter, 2007. "Independent economic regulation: A reassessment of its role in sustainable development," Utilities Policy, Elsevier, vol. 15(4), pages 261-269, December.
    6. Cambrosio, Alberto & Campbell, Jonah & Keating, Peter & Polk, Jessica B. & Aguilar-Mahecha, Adriana & Basik, Mark, 2022. "Healthcare policy by other means: Cancer clinical research as “oncopolicy”," Social Science & Medicine, Elsevier, vol. 292(C).
    7. Malte Hückstädt, 2022. "Coopetition between frenemies–interrelations and effects of seven collaboration problems in research clusters," Scientometrics, Springer;Akadémiai Kiadó, vol. 127(9), pages 5191-5224, September.
    8. Cunha, Bruno Queiroz & Pereira, Ana Karine & Gomide, Alexandre de Ávila, 2017. "State capacity and utilities regulation in Brazil: Exploring bureaucracy," Utilities Policy, Elsevier, vol. 49(C), pages 116-126.
    9. Lyall, Catherine & Tait, Joyce, 2019. "Beyond the limits to governance: New rules of engagement for the tentative governance of the life sciences," Research Policy, Elsevier, vol. 48(5), pages 1128-1137.
    10. Anders Cour & Holger Højlund, 2017. "Polyphonic Supervision," Systems Research and Behavioral Science, Wiley Blackwell, vol. 34(2), pages 148-162, March.
    11. Melanie Levy, 2022. "The rise of the Swiss regulatory healthcare state: On preserving the just in the quest for the better (or less expensive?)," Regulation & Governance, John Wiley & Sons, vol. 16(2), pages 427-447, April.
    12. Minogue, Martin, 2005. "Apples and Oranges: Problems in the Analysis of Comparative Regulatory Governance," Centre on Regulation and Competition (CRC) Working papers 30589, University of Manchester, Institute for Development Policy and Management (IDPM).
    13. Shuo Xu & Liyuan Hao & Xin An & Hongshen Pang & Ting Li, 2020. "Review on emerging research topics with key-route main path analysis," Scientometrics, Springer;Akadémiai Kiadó, vol. 122(1), pages 607-624, January.
    14. Alberto Onetti & Hal Steger, 2007. "Formulating an open source business model requires community segmentation and targeted marketing," Economics and Quantitative Methods qf0707, Department of Economics, University of Insubria.
    15. Kirkpatrick, Colin & Parker, David, 2004. "Regulation and the Privatisation of Water Services in Developing Countries: Assessing the Impact of the General Agreement on Trade in Services (GATS)," Centre on Regulation and Competition (CRC) Working papers 30600, University of Manchester, Institute for Development Policy and Management (IDPM).
    16. Alessia Pisoni & Alberto Onetti & Luciano Fratocchi & Marco Talaia, 2010. "Managing R&D activities in the Italian red biotech industry. A comparison between Italian independent firms and multinational companies," Economics and Quantitative Methods qf1003, Department of Economics, University of Insubria.
    17. Dimitar Anguelov, 2024. "State‐owned Enterprises and the Politics of Financializing Infrastructure Development in Indonesia: De‐risking at the Limit?," Development and Change, International Institute of Social Studies, vol. 55(3), pages 493-529, May.
    18. Tylecote, Andrew, 2019. "Biotechnology as a new techno-economic paradigm that will help drive the world economy and mitigate climate change," Research Policy, Elsevier, vol. 48(4), pages 858-868.
    19. Fabio Sorrentino & Francesco Garraffo, 2012. "Explaining performing R&D through alliances: Implications for the business model of Italian dedicated biotech firms," Journal of Management & Governance, Springer;Accademia Italiana di Economia Aziendale (AIDEA), vol. 16(3), pages 449-475, August.
    20. Tanja Börzel & Adam Fagan, 2015. "Environmental governance in South East Europe/Western Balkans: reassessing the transformative power of Europe," Environment and Planning C, , vol. 33(5), pages 885-900, October.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:wly:reggov:v:15:y:2021:i:3:p:969-986. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: https://doi.org/10.1111/(ISSN)1748-5991 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.